Search
# Popular search #
0%
# Popular search #
Stock Code
603087.SHGan & Lee Pharmaceuticals Signs License and Supply Agreement with PC to Accelerate Global Rollout of Bofanglutide (GZR18) Biweekly GLP-1 RA
World Diabetes Day Initiative | Gan & Lee Launches Global Public Welfare Initiative for World Diabetes Day
Gan & Lee Showcases Core Achievements at CPHI Worldwide 2025
Witnessed by the Brazilian Ministry of Health, Gan & Lee and Fiocruz Sign Memorandum of Understanding to Explore New Directions in Innovative Drug Cooperation
Gan & Lee Pharmaceuticals Names Dr. Ting JIA as Corporate Vice President and Chief Medical Officer to Accelerate Global Expansion of Innovative Drugs
Major Collaboration | Gan & Lee Signs National “Technology Transfer and Supply Agreement” in Brazil to Accelerate Local Insulin Manufacturing
To be a world-class pharmaceutical company with focus on global business development
Registered in 23 countries
Products launched in 19 countries
Clinical trials conducted in 10 countries
Registered in 23 countries
Products launched in 19 countries
Clinical trials conducted in 10 countries
This website uses cookies to give users like yourself the best possible content and experience. For more information about your choices regarding cookies, please review our Privacy Policy .
The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.
